Company News
UDG Healthcare reaches acquisition agreement with MicroMass
Healthcare services group UDG Healthcare announced on Thursday that it had reached an acquisition agreement with US-based communications agency MicroMass Communication to absorb the business for a total consideration of $75. 8m.
NetScientific's ProAxsis appoints Diagenics as UK distributor
Health care intellectual property commercialisation group NetScientific announced an update for its portfolio company ProAxsis on Thursday.
Government refers Sky-Fox deal for CMA probe
Sky's takeover by 21st Century Fox has been referred by Culture Secretary Karen Bradley for an in-depth investigation over concerns over broadcasting standards and 'media plurality'.
John Lewis profits halved after costly restructure
UK-based retail group John Lewis announced on Thursday that it had seen its profits cut in half during its first six months of trading as it was hit hard with costs from the reorganisation of its business model.
Corero Network Security wins 'significant' contract
AIM-listed Corero Network Securitiy has won a "significant" contract for its SmartWall Threat Defence Systems.
Bwin acquisition continues to drive GVC in first half
Sports betting and gaming provider GVC Holdings posted a 10% proforma improvement in its net gaming revenue for the first half on Thursday, or 12% at constant currency, to €486. 2m, while its total revenue was ahead 9% at €472. 8m, or 11% at constant currency.
Cenkos Securities appoints Philip Anderson as finance director
Cenkos Securities has appointed Philip Anderson - a former chief financial of Virgin Money - as finance director with immediate effect.
Colefax current trading in line with expectations
AIM-listed Colefax said on Thursday that current trading is in line with management expectations.
Interserve tanks on profit warning
Shares in Interserve plummeted on Thursday as the supports services and construction group said its outturn for the year will be "significantly below" its previous expectations following disappointing trading in July and August.
Reabold Resources in talks regarding 'significant' placing
AIM-listed Reabold Resources confirmed on Thursday that it is in discussions regarding a "significant" placing.
UK weakness at Safestore in Q3 offset by strong showing in France
Safestore reiterated its full-year guidance despite posting what appeared to be weaker-than-expected like-for-like sales in the UK.
JD Sports agrees to combine Iberian stores with Sport Zone
Sports, fashion and outdoor brands retailer JD Sports Fashion announced on Thursday that it has now exchanged conditional contracts to combine its existing business in Iberia, JD Sprinter Holdings (JDSH), with the Sport Zone business, which is a subsidiary of Sonae and one of the largest sports retailers in Spain and Portugal.
Thomas Cook announces tie-up with Expedia
Thomas Cook has entered into a strategic alliance with Expedia, whereby the US company will become the preferred provider of hotels for Thomas Cook and provide its booking platform to support all city break and hotel-only sales in Europe.
GlaxoSmithKline's shingles vaccine a step closer to possible FDA approval
GlaxoSmithKline announced on Thursday that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration voted unanimously that its data supported the efficacy and safety of its ‘Shingrix’ product, for the prevention of herpes zoster (shingles) in adults ages 50 and over.
Booker second-quarter sales up 1.3%
FTSE 250 wholesaler Booker, which has agreed to be taken over by Tesco, reported a 1. 3% jump in second-quarter like-for like sales on Thursday thanks to a solid performance from both the catering and retail sides of the business.
AstraZeneca offloads remaining anaesthetic rights to Aspen
AstraZeneca has entered into an agreement with Aspen Global Incorporated - part of the Aspen Group - under which AGI will now acquire the residual rights to the established anaesthetic medicines Diprivan, EMLA, Xylocaine/Xylocard/Xyloproct, Marcaine, Naropin, Carbocaine and Citanest, it announced on Thursday.